Author:
Saroya Amritpal Singh,Singh Jaswinder
Reference35 articles.
1. Becker A, Felgentreff F, Schröder H, Meier B, Brattström A. The anxiolytic effects of a valerian extract is based on valerenic acid. BMC Complement Altern Med. 2014;14:267.
2. Benke D, Barberis A, Kopp S, Altmann KH, Schubiger M, Vogt KE, Rudolph U, Möhler H. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology. 2009;56:174–81.
3. Boeters U. Treatment of control disorders of the autonomic nervous system with valepotriate (Valmane). Munch Med Wochenschr. 1969;111:1873–6.
4. Castillo P, Zamilpa A, Márquez J, Hernández G, Lara M, Alvarez L. Comparative study of differentiation levels and valepotriate content of in vitro cultures and regenerated and wild plants of Valeriana edulis ssp. procera. J Nat Prod. 2002;65:573–5.
5. Cavadas C, Araújo I, Cotrim MD, Amaral T, Cunha AP, Macedo T, Ribeiro CF. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung. 1995;45:753–5.